Representative Experience

In recent years, we have completed over $20 billion in venture financings and have stewarded many unicorns as well as emerging companies from formation to valuations in excess of $1 billion. Some of our relationships include:

  • Represented JUUL Labs in its $12.8 billion investment by Altria at a $38.5 billion post-money valuation.
  • Represented the first “unicorn” in New York, in its organization and six rounds of venture capital financing with proceeds of over $300 million.
  • Represented Business Insider, one of the most popular business websites, through its formation, including incorporation, seven rounds of venture capital, and its $343 million sale to German media company Axel Springer SE.

View More

  • Represented Nicira from its incorporation in 2007 through several rounds of financing, corporate matters, employee benefits, tax, IP and related matters, until its sale to VMWare for $1.26 billion.
  • Represented Atheros, formed in a Pillsbury conference room, in its multiple financings, managing various corporate matters, its $126 million IPO, various M&A transactions and ultimate $3.6 billion sale to Qualcomm.
  • Represented WebEx Communications Inc. through its formation, its venture capital financings, its IPO and its sale to Cisco Systems for $3.1 billion.

Practice Area Highlights

  • Chambers USA recognized Pillsbury’s Startups & Emerging Companies practice as a national leader and ranked our Venture Capital practice regionally in California (2024–2025).
  • Best Lawyers awarded Pillsbury a national Tier 2 ranking for Venture Capital Law (2021–2025).
  • Recognized by The Legal 500 U.S. for Venture Capital and Emerging Companies (2024–2025).

View More

  • Recognized by The Legal 500 UK  for Emerging Markets (2025–2026.

Sector

  •  #4 for most active in IT hardware VC financings
  • #6 for most active in energy VC financings
  • #6 for most active in healthcare devices & supplies VC financings
  • #6 for most active in healthcare services & systems VC financings
  • #6 for most active in media VC financings
  • #8 for most active in pharma & biotech VC financings
  • #8 for most active in commercial products & services VC financings
  • #10 for most active in software VC financings

Regional

  • #5 for most active in the Southeast for VC financings
  • #6 for most active in Mid-Atlantic for VC financings
  • #8 for most active in Central & Eastern Europe for VC financings
  • #9 for most active in the West Coast for VC financings
  • #9 for most active in UK & Ireland for VC financings
  • #10 for most active in the South for VC financings
  • #15 for most active in in Israel for VC financings
  • #22 for most active in the Nordics for VC financings

Geography

  • #8 for most active globally for VC financings
  • #9 for most active in the U.S. for VC financings

Deal Type

  • #7 for most active at late stage VC financings
  • #8 for most active at early stage VC financings

Representation

  • #7 for most active in the U.S. for representing investors
  • #7 for most active in the U.S. for representing companies
  • #7 for most active globally for representing investors
  • #8 for most active globally for representing companies